Giorgio Corti

This paper introduces μSeq, a method for accurately quantifying mutation rates using deep sequencing of single clonal expansions, showing it outperforms existing methods in robustness and accuracy.

XENTURION provides a resource of PDX models and tumoroids from metastatic CRC patients, revealing variable cetuximab responses and identifying therapeutic targets through cross-platform validation.